Bio-Techne Cp (TECH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | TECH | SRPT | RGEN | ||
Company | Bio-Techne Cp | Sarepta Therapeutics | Repligen Cp | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 63.22 | 117.66 | 169.82 | ||
High | 63.94 | 125.13 | 173.48 | ||
Low | 62.61 | 117.21 | 165.91 | ||
Last | 63.52 | 124.25 | 167.86 | ||
Change | -0.17 | +7.13 | -3.42 | ||
% Change | -0.27% | +6.09% | -2.00% | ||
Volume | 984,800 | 1,500,000 | 545,900 | ||
20-Day Average Volume | 976,865 | 671,155 | 488,460 | ||
Previous Close | 63.69 | 117.12 | 171.28 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | Yes | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 66.55 | 123.24 | 171.78 | ||
20-Day Raw Stochastic | 23.34% | 58.84% | 44.69% | ||
20-Day Relative Strength | 38.64% | 52.37% | 42.29% | ||
Weighted Alpha | -22.11 | +15.50 | +1.63 | ||
Today's Opinion | 88% Sell | 56% Buy | 24% Sell | ||
Previous Opinion | 88% Sell | 40% Buy | 8% Sell | ||
Last Month's Opinion | 24% Sell | 72% Buy | 56% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | +1.26% since 04/17/24 | +5.39% since 04/17/24 | +4.27% since 04/17/24 | ||
Low | 61.16 on 04/18/24 | 114.37 on 04/19/24 | 152.19 on 04/18/24 | ||
High | 64.58 on 04/23/24 | 125.13 on 04/24/24 | 174.30 on 04/23/24 | ||
1-Month | |||||
%Chg | -11.16% since 03/22/24 | -2.58% since 03/22/24 | -15.24% since 03/22/24 | ||
Low | 61.16 on 04/18/24 | 114.37 on 04/19/24 | 152.19 on 04/18/24 | ||
High | 71.75 on 03/25/24 | 131.16 on 03/28/24 | 198.00 on 03/25/24 | ||
3-Month | |||||
%Chg | -10.61% since 01/24/24 | +3.35% since 01/24/24 | -7.64% since 01/24/24 | ||
Low | 61.16 on 04/18/24 | 114.37 on 04/19/24 | 152.19 on 04/18/24 | ||
High | 78.75 on 03/08/24 | 143.00 on 02/16/24 | 211.13 on 02/16/24 | ||
6-Month | |||||
%Chg | -0.17% since 10/24/23 | +9.55% since 10/24/23 | +20.09% since 10/24/23 | ||
Low | 51.79 on 11/01/23 | 55.25 on 10/31/23 | 110.45 on 10/30/23 | ||
High | 78.75 on 03/08/24 | 143.00 on 02/16/24 | 211.13 on 02/16/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 10,011,558 | 10,997,569 | 9,564,104 | ||
Shares Outstanding, K | 157,192 | 93,900 | 55,839 | ||
Annual Sales | 1,136,700,000 | 1,243,340,000 | 638,760,000 | ||
Annual Net Income | 285,260,000 | -535,980,000 | 41,580,000 | ||
Last Quarter Sales | 272,600,000 | 396,780,000 | 155,740,000 | ||
Last Quarter Net Income | 27,470,000 | 45,650,000 | -25,490,000 | ||
60-Month Beta | 1.22 | 0.94 | 1.02 | ||
Per-Share Information | |||||
Most Recent Earnings | 0.40 on 02/01/24 | 0.47 on 02/28/24 | 0.33 on 02/21/24 | ||
Latest Earnings Date | 05/01/24 | 05/07/24 | 05/01/24 | ||
Most Recent Dividend | 0.080 on 02/09/24 | N/A | N/A | ||
Next Ex-Dividends Date | 02/09/24 | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 36.73 | 0.00 | 91.03 |